Report Categories
View AllRecent Articles
View All
Nektar Therapeutics NKTR Top Gainer Nektar Therapeutics beats EPS estimates by 295
Vision VMAR Stock Trend Strength Smart Money Flows 20260418
Is Security SNFCA stock worth including in a portfolio Q4 2025 Earnings Report
SeaStar ICU Stock Discretionary Trade 293 20260415
How Carpenter CRS cash flow tells the real story Selling Pressure 20260507
Market Recap Tech leads broad market gains while consumer sector lags
Perfect Moment PMNT Stock 52Week High Bearish Sentiment 20260415
What Chime CHYM does that its rivals cannot replicate Q4 2025 EPS Tops Views
Simon Property Group Inc SPG Remains Top Holding of Smead Value Fund Amid Q1 2026 Portfolio Rebalancing
BPRE Bluerock RE leadership outlines strategic residential asset expansion plans to lift upcoming quarterly performance
CII BlackRock Fd quarterly earnings metrics remain unannounced as investors await official performance updates and market guidance
What Lantern Pharma LTRN is doing to protect its market share Trend Weakens 20260508
The key risks discussed in Celanese CE earnings Celanese posts 286 EPS miss amid margin pressure
Prologis Inc PLD Reports Q1 2026 FFO and Revenue Beat Driven by Robust Industrial Leasing Demand
Target Corporation TGT Bullish Thesis Underscores Structural Turnaround Potential and Attractive RiskReward Profile